KIDS
Q3 2026 EPS Estimate
$-0.31
Aug 4, 2026 · Reports after close
Revenue Estimate
$68M
FY2029E EPS$0.19
FY2030E EPS$0.91

Analyst Sentiment

Wall St. Consensus
Buy
13 analysts·Moderate coverage
73
Score
12 Buy (92%)1 Hold (8%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1292%
Hold
18%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$17.00
-16.3%
Consensus
$21.00
+3.4%
Bull
$25.00
+23.2%
12-Month Target Range13 analysts
$17.00$21.00$25.00
Current $20.30Consensus
Current Price
$20.30
Upside to Consensus
$0.70

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+11.86%
EPS
FY2028
Rev+11.39%
EPS
FY2029
Rev+12.23%
EPS
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$265M$297M$330M$371M$413M
Low$265M$296M$330M$370M$412M
High$265M$297M$330M$372M$414M
EBITDA Avg$-11M$-12M$-14M$-15M$-17M
Low$-11M$-12M$-14M$-15M$-17M
High$-11M$-12M$-14M$-15M$-17M
EBIT Avg$-28M$-32M$-35M$-39M$-44M
Low$-28M$-32M$-35M$-40M$-44M
High$-28M$-32M$-35M$-39M$-44M
Net Income Avg$-28M$-19M$-6M$4M$21M
Low$-28M$-19M$-32M$4M$21M
High$-28M$-19M$8M$4M$21M
EPS Avg$-1.18$-0.81$-0.29$0.19$0.91
Low$-1.19$-0.81$-1.34$0.19$0.91
High$-1.18$-0.81$0.36$0.19$0.91
Analysts (Rev / EPS)6 / 56 / 54 / 33 / 13 / 1
Quarterly
MetricQ2 2026Q3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028
Revenue Avg$68M$69M$68M$66M$76M$78M$76M$74M
Low$68M$69M$68M$66M$76M$77M$76M$74M
High$68M$69M$69M$67M$77M$78M$77M$74M
EBITDA Avg$-3M$-3M$-3M$-3M$-3M$-3M$-3M$-3M
Low$-3M$-3M$-3M$-3M$-3M$-3M$-3M$-3M
High$-3M$-3M$-3M$-3M$-3M$-3M$-3M$-3M
EBIT Avg$-7M$-7M$-7M$-7M$-8M$-8M$-8M$-8M
Low$-7M$-7M$-7M$-7M$-8M$-8M$-8M$-8M
High$-7M$-7M$-7M$-7M$-8M$-8M$-8M$-8M
Net Income Avg$-7M$-5M$-5M$-7M$-5M$-3M$-4M$-8M
Low$-7M$-5M$-5M$-7M$-5M$-3M$-4M$-8M
High$-7M$-5M$-5M$-7M$-5M$-3M$-4M$-8M
EPS Avg$-0.30$-0.21$-0.22$-0.31$-0.19$-0.13$-0.18$-0.34
Low$-0.30$-0.21$-0.22$-0.31$-0.19$-0.13$-0.18$-0.34
High$-0.30$-0.21$-0.22$-0.31$-0.19$-0.12$-0.18$-0.34
Analysts (Rev / EPS)5 / 35 / 32 / 12 / 12 / 12 / 12 / 11 / 1

Earnings Surprises

Recent Analyst Actions

May 1, 2026Truist Financial
OrthoPediatrics price target lowered to $17 from $20 at Truist
Target:$17.00
+10.0%from $15.45
Apr 24, 2026Canaccord Genuity
OrthoPediatrics price target raised to $25 from $24 at Canaccord
Target:$25.00
+54.2%from $16.21
Dec 10, 2025Canaccord Genuity
Canaccord starts OrthoPediatrics with a Buy after guidance reset
Target:$24.00
+30.9%from $18.34
Oct 29, 2025Needham
OrthoPediatrics Corp. (KIDS) PT Lowered to $26 at Needham
Target:$26.00
+53.8%from $16.91
Oct 10, 2025Truist Financial
OrthoPediatrics price target lowered to $18 from $22 at Truist
Target:$18.00
+15.4%from $15.60
Oct 10, 2025Lake Street
OrthoPediatrics price target lowered to $34 from $37 at Lake Street
Target:$34.00
+118.7%from $15.55
Oct 10, 2025BTIG
OrthoPediatrics price target lowered to $23 from $39 at BTIG
Target:$23.00
+28.1%from $17.95
Oct 10, 2025JMP Securities
OrthoPediatrics price target lowered to $25 from $35 at Citizens JMP
Target:$25.00
+39.3%from $17.95
Oct 10, 2025Stifel Nicolaus
OrthoPediatrics price target lowered to $20 from $32 at Stifel
Target:$20.00
+11.4%from $17.95
Oct 10, 2025Piper Sandler
OrthoPediatrics price target lowered to $22 from $30 at Piper Sandler
Target:$22.00
+22.6%from $17.95
Aug 8, 2025JMP Securities
OrthoPediatrics Corp. (KIDS) PT Lowered to $35 at Citizens JMP
Target:$35.00
+82.3%from $19.20
Mar 5, 2025Stifel Nicolaus
OrthoPediatrics price target lowered to $32 from $40 at Stifel
Target:$32.00
+25.0%from $25.61
Oct 14, 2024Truist Financial
OrthoPediatrics price target lowered to $28 from $34 at Truist
Target:$28.00
+9.5%from $25.57
Sep 13, 2024Needham
Needham Reiterates Buy Rating on OrthoPediatrics Corp. (KIDS)
Target:$42.00
+32.9%from $31.60
Sep 13, 2024Truist Financial
OrthoPediatrics Corp. (KIDS) PT Raised to $34 at Truist Securities
Target:$34.00
+7.6%from $31.60
Sep 6, 2024Piper Sandler
Piper Sandler Reiterates Overweight Rating on OrthoPediatrics Corp. (KIDS)
Target:$44.00
+47.3%from $29.88
Sep 6, 2024BTIG
BTIG Reiterates Buy Rating on OrthoPediatrics Corp. (KIDS)
Target:$44.00
+47.3%from $29.88
Jul 16, 2024Truist Financial
OrthoPediatrics price target lowered to $35 from $38 at Truist
Target:$35.00
+1.6%from $34.44
May 7, 2024Stifel Nicolaus
OrthoPediatrics Corp. (KIDS) PT Raised to $40 at Stifel
Target:$40.00
+15.3%from $34.70
Aug 5, 2022Truist Financial
Truist Securities Maintains Buy on OrthoPediatrics, Raises Price Target to $66
Target:$66.00
+19.9%from $55.06
Jul 18, 2022BTIG
BTIG Maintains Buy on OrthoPediatrics, Lowers Price Target to $61
Target:$61.00
+41.9%from $42.99
Jul 18, 2022Stifel Nicolaus
Stifel Maintains Buy on OrthoPediatrics, Lowers Price Target to $50
Target:$50.00
+16.3%from $42.99
May 5, 2022Needham
Needham Maintains Buy on OrthoPediatrics, Lowers Price Target to $59
Target:$59.00
+33.7%from $44.13
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.